Transcatheter valve implantation for patients with aortic stenosis

Vahanian, Alec; Himbert, Dominique; Brochet, Eric
November 2010
Heart;Nov2010, Vol. 96 Issue 22, p15
Academic Journal
The article offers information on a study which compared two commercially available devices for transcatheter aortic valve implantation (TAVI). It briefly mentions treatment options for aortic stenosis, including valve replacement, surgery and balloon aortic valvuloplasty (BAV). The devices evaluated in the study are the Edwards-Sapien valve, which consists of three bovine pericardial leaflets mounted within a tubular, slotted, stainless steel, balloon expandable stent, and the Medtronic CoreValve, which consists of three porcine pericardial leaflets.


Related Articles

  • Aortic Stenosis: Complications in Noncardiac Surgery. Miller, Karl E. // American Family Physician;11/1/2004, Vol. 70 Issue 9, p1794 

    Discusses research being done on aortic stenosis that may be a risk factor for perioperative complications in patients undergoing noncardiac surgery. Reference to a study by M. D. Kertai et al published in the January 1, 2004 issue of the "American Journal of Medicine"; Findings of the study;...

  • Redo-redo aortic root replacement with a mechanical valved conduit in a patient with von Willebrand¿s disease: Case report. Shaikhrezai, Kasra; Bashir, Usman; Millar, Sheena; Anderson, Julia; Brackenbury, Edward T. // Journal of Cardiothoracic Surgery;2010, Vol. 5, p59 

    A 40 year-old female, with a history of cardiac surgery for congenital aortic valve stenosis and von Willebrand's disease (VWD) presented with increasing shortness of breath due to mixed aortic valve dysfunction. With a paucity of such cases in the literature, we describe the successful outcome...

  • Značaj natriuretskih peptida u proceni težine aortne stenoze. Davičević, Žaklina; Tavčiovski, Dragan; Matunović, Radomir; Vukotić, Snježana; Mijailović, Zdravko // Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journ;Aug2010, Vol. 67 Issue 8, p622 

    Background/Aim. Symptom onset is a critical point in natural course of aortic stenosis and the most important indication for aortic valve replacement. The aim of the study was to evaluate the role of natriuretic peptides level in the assessment of symtomatic status of patients with severe aortic...

  • Aortic valve replacement with continuously perfused beating heart in patients with patent bypass conduits Sutherland, Fraser W.H.; West, Mark; Pathi, Vivek // European Journal of Cardio-Thoracic Surgery;Oct2004, Vol. 26 Issue 4, p834 

    We present a technique for replacement of the aortic valve in selected patients undergoing redo surgery in the presence of patent coronary artery bypass grafts and occluded native coronary arteries that affords optimal myocardial protection, limited dissection of the heart and minimal risk of...

  • Congenital Valvular Aortic Stenosis.  // Clinical Pediatrics;Oct1966, Vol. 5 Issue 10, p617 

    Discusses the results of an open forum on congenital valvular aortic stenosis participated by two physicians from the Massachusetts General Hospital. Contention on a case of a six-year old male admitted to the hospital for evaluation of a heart murmur; Details of the open heart surgery;...

  • PARTNER Cohort B: TAVI Superior to Standard Therapy at Two Years.  // MD Conference Express;Dec2011, p5 

    The article focuses on the recommended treatment for inoperable patients with severe aortic stenosis (AS), based on the result of the PARTNER trial. It notes that the trial was conducted to assess clinical outcomes of transcatheter aortic valve implantation (TAVI) compared to the standard...

  • The multiparametric FRANCE-2 risk score: one step further in improving the clinical decision-making process in transcatheter aortic valve implantation. Ribeiro, Henrique B.; Rodés-Cabau, Josep // Heart;Jul2014, Vol. 100 Issue 13, p993 

    The authors reflect on an article "Predictive Factors of Early Mortality after Transcatheter Aortic Valve Implantation: Individual Risk Assessment Using a Simple Score" by B. Lung, and colleagues. They discuss transcatheter aortic valve implantation (TAVI) technique as a less invasive treatment...

  • Alternative access shows promise in extreme-risk patients treated with CoreValve.  // Cardiology Today;Jun2014, Vol. 17 Issue 6, p26 

    The article presents a medical report which suggests that treatment with CoreValve System through alternative access routes proved to be beneficial for extreme-risk patients with sever aortic stenosis.

  • Calcific aortic stenosis: from bench to the bedside--emerging clinical and cellular concepts. Rajamannan, Nalini M.; Gersh, Bernard; Bonow, Robert O. // Heart;Jul2003, Vol. 89 Issue 7, p801 

    Describes calcific aortic stenosis as the cause of aortic valve disease in developed countries. Increase in the prevalence of the disease; Cellular basis of calcific aortic stenosis; Occurrence of the disease in the left ventricular hypertrophy.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics